Originally published byEU-Startups
GenePlanet, a Ljubljana-based genomics and laboratory platform delivering advanced genetic testing and next-generation sequencing (NGS) services worldwide, has secured a strategic investment from Lauxera Capital Partners, a specialist HealthTech investor. With this investment, the company’s existing investor BlackPeak Capital has partially exited its investment. It, however, retains a meaningful shareholding in the Slovenian company. Niklas […]
The post “Now there is a real chance to become a unicorn”: Slovenia’s GenePlanet secures strategic investment from Lauxera appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Bypassing AI guardrails is so easy a script kiddie can do it
5h ago
As Larry Ellison bets the farm, Oracle says it loves AI-written code, just not in OpenJDK
1d ago
AI is 'both the weapon and the target' in latest wave of cyberattacks
1d ago
Helsinki-based Aiforia secures €20 million EIB financing to advance AI-powered cancer diagnostics
1d ago
Unexpected item in the bagging area as Windows Activation error pops up at check-in
3d ago